Journal
TUMOR BIOLOGY
Volume 35, Issue 9, Pages 8999-9007Publisher
SAGE PUBLICATIONS LTD
DOI: 10.1007/s13277-014-2170-z
Keywords
Tissue inhibitor of metalloproteinase-3; Tissue inhibitor of metalloproteinase-4; Single nucleotide polymorphism; Hepatocellular carcinoma
Categories
Funding
- National Science Council, Taiwan [NSC102-2314-B-040-002]
Ask authors/readers for more resources
The purpose of this study was to investigate genetic impact of TIMP-3 -1296 T > C (rs9619311) and TIMP-4 -55 T > C (rs3755724) gene polymorphisms on the susceptibility and clinicopathological characteristics of hepatocellular carcinoma (HCC). A total of 759 subjects, including 530 healthy controls and 229 patients with hepatocellular carcinoma, were recruited in this study. Allelic discrimination of TIMP-3 -1296 T > C (rs9619311) and TIMP-4 -55 T > C (rs3755724) polymorphisms was assessed with the ABI StepOne (TM) Real-Time PCR System. Among women group, individuals with TC or CC alleles of TIMP-3 -1296 T > C gene polymorphism protected against HCC (AOR = 0.35, 95% confidence interval (CI) = 0.12-0.97; p = 0.04) compared to individuals with TT alleles, after adjusting for other confounders. Also, women with TC alleles and with TC or CC alleles of TIMP-4 -55 T > C polymorphisms had a 2.52-fold risk (95%CI = 1.23-5.13; p = 0.01) and 2.47-fold risk (95%CI = 1.26-4.87; p = 0.008) of developing HCC compared to individuals with TT alleles, after adjusting for other confounders. There was no synergistic effect between gene polymorphism and environmental risk factors, including tobacco and alcohol consumptions and clinical statuses of HCC as well as serum expression of liver-related clinicopathological markers. In conclusion, gene polymorphisms of TIMP-3 -1296 T > C (rs9619311) and TIMP-4 -55 T > C (rs3755724) play a role in the susceptibility of HCC among Taiwan women.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available